<DOC>
	<DOCNO>NCT01198769</DOCNO>
	<brief_summary>The purpose study assess immunogenicity safety Rotarix TM administer healthy Taiwanese infant ( age 6 12 week time first vaccination ) receive Hepatitis B immunoglobulin birth .</brief_summary>
	<brief_title>Immunogenicity Safety Study Rotarix TM Taiwanese Infants Who Received Hepatitis B Immunoglobulin After Birth .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Rotavirus Infections</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>Subjects investigator believe parent ( ) /Legally Acceptable Representative ( ) comply requirement protocol . A male female , include , 6 12 week age time first vaccination . Written inform consent obtain parent ( ) /Legally Acceptable Representative ( ) subject . Healthy subject establish medical history clinical examination enter study . Infants receive previous dose hepatitis B immunoglobulin birth . Child care . Use investigational nonregistered product study vaccine within 30 day precede first dose study vaccine , plan use study period . Chronic administration immunosuppressant immunemodifying drug exception Hepatitis B immunoglobulin since birth . Child unlikely remain study area duration study . Planned administration/administration vaccine foreseen study protocol within 30 day first dose vaccine . Concurrently participate another clinical study , time study period , subject expose investigational noninvestigational product . Previous vaccination rotavirus . Any confirm suspected immunosuppressive immunodeficient condition , base medical history physical examination . Family history congenital hereditary immunodeficiency . History reaction hypersensitivity likely exacerbate component vaccine . Major congenital defect serious chronic illness . Acute disease and/or fever time enrolment . Administration immunoglobulin ( exception HBIG ) and/or blood product since birth plan administration study period . Gastroenteritis within 7 day precede study vaccine administration . Previous confirm occurrence Rotavirus gastroenteritis .</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>12 Weeks</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Human rotavirus vaccine</keyword>
</DOC>